These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2476133)
41. Use of a peptide based enzyme immunoassay in diagnosis of Chlamydia trachomatis triggered reactive arthritis. Nikkari S; Puolakkainen M; Närvänen A; Aakre O; Toivanen P; Leirisalo-Repo M J Rheumatol; 2001 Nov; 28(11):2487-93. PubMed ID: 11708423 [TBL] [Abstract][Full Text] [Related]
43. Antibody-mediated disease remission in the mouse model of lyme borreliosis. Barthold SW; Hodzic E; Tunev S; Feng S Infect Immun; 2006 Aug; 74(8):4817-25. PubMed ID: 16861670 [TBL] [Abstract][Full Text] [Related]
44. Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice. Ekerfelt C; Andersson M; Olausson A; Bergström S; Hultman P Clin Exp Immunol; 2007 Oct; 150(1):189-97. PubMed ID: 17672870 [TBL] [Abstract][Full Text] [Related]
45. An IgE response to spirochete antigen in patients with Lyme disease. Benach JL; Gruber BL; Coleman JL; Habicht GS; Golightly MG Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):127-32. PubMed ID: 2437736 [TBL] [Abstract][Full Text] [Related]
46. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease. Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170 [TBL] [Abstract][Full Text] [Related]
48. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Nanagara R; Li F; Beutler A; Hudson A; Schumacher HR Arthritis Rheum; 1995 Oct; 38(10):1410-7. PubMed ID: 7575691 [TBL] [Abstract][Full Text] [Related]
49. Rational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment. Blaauw I; Dijkmans B; Bouma P; van der Linden S Ann Rheum Dis; 1993 Mar; 52(3):206-10. PubMed ID: 8484673 [TBL] [Abstract][Full Text] [Related]
50. The antibody response in Lyme disease. Craft JE; Grodzicki RL; Shrestha M; Fischer DK; García-Blanco M; Steere AC Yale J Biol Med; 1984; 57(4):561-5. PubMed ID: 6393607 [TBL] [Abstract][Full Text] [Related]
51. [The incidence of Lyme arthritis and of antibodies to Borrelia burgdorferi in rheumatology patients in an endemic area]. Lesniak OM; Sokolova ZI; Laĭkovskaia EE; Riabitseva OF Ter Arkh; 1994; 66(5):45-7. PubMed ID: 7940338 [TBL] [Abstract][Full Text] [Related]
52. Serological studies in Chlamydia trachomatis associated pneumonia of infants. Marton A; Szirmai Z; Szever Z; László V Acta Microbiol Hung; 1986; 33(1):51-4. PubMed ID: 3529795 [TBL] [Abstract][Full Text] [Related]
53. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Liu N; Montgomery RR; Barthold SW; Bockenstedt LK Infect Immun; 2004 Jun; 72(6):3195-203. PubMed ID: 15155621 [TBL] [Abstract][Full Text] [Related]
54. IgM rheumatoid factor in Lyme disease: correlation with disease activity, total serum IgM, and IgM antibody to Borrelia burgdorferi. Kujala GA; Steere AC; Davis JS J Rheumatol; 1987 Aug; 14(4):772-6. PubMed ID: 3668982 [TBL] [Abstract][Full Text] [Related]
55. The responsiveness of human V delta 1 gamma delta T cells to Borrelia burgdorferi is largely restricted to synovial-fluid cells from patients with Lyme arthritis. Glatzel A; Entschladen F; Zollner TM; Kraiczy P; Brade V; Kaufmann R; Janssen O; Lengl-Janssen B; Wesch D; Kabelitz D J Infect Dis; 2002 Oct; 186(7):1043-6. PubMed ID: 12232849 [TBL] [Abstract][Full Text] [Related]
56. Use of an autologous antigen in the serologic testing of patients with erythema migrans of Lyme disease. Berger BW; MacDonald AB; Benach JL J Am Acad Dermatol; 1988 Jun; 18(6):1243-6. PubMed ID: 3290287 [TBL] [Abstract][Full Text] [Related]
57. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918 [TBL] [Abstract][Full Text] [Related]
58. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. Drouin EE; Glickstein LJ; Steere AC J Autoimmun; 2004 Nov; 23(3):281-92. PubMed ID: 15501399 [TBL] [Abstract][Full Text] [Related]
59. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Vaz A; Glickstein L; Field JA; McHugh G; Sikand VK; Damle N; Steere AC Infect Immun; 2001 Dec; 69(12):7437-44. PubMed ID: 11705918 [TBL] [Abstract][Full Text] [Related]
60. The mammalian host response to borrelia infection. Cadavid D Wien Klin Wochenschr; 2006 Nov; 118(21-22):653-8. PubMed ID: 17160603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]